Stage 2 Works is an independent research institution dedicated to developing foundational physics insights across every market they touch. We incubate deep-tech breakthroughs that require patient capital and integrated expertise, spinning them out into the world’s most transformative companies.
Our core research is centered on a unified geometric framework of electron behavior, formalized over 30 years of mathematical development. Through first-principles simulation, we are building the foundation for next-generation quantum computing, fusion materials, and superconductor optimization.
We pursue government research grants, national laboratory partnerships, and academic collaborations to advance this fundamental science — work that operates on timescales incompatible with traditional venture capital but essential to long-term technological progress.
Breakthrough physics cannot be forced into a 10-year venture capital lifecycle. Stage 2 Works acts as the institutional backer.
We develop the core science with patient capital, pursuing insights that require decades of mathematical and experimental work.
When fundamental insights reveal commercial applications, we build integrated teams of scientists, engineers, and business operators under one roof.
When an application reaches commercial readiness, we spin it out into an independent, venture-backed company positioned to scale.
Materials Discovery Engine
Spun out of Stage 2 Works, Velar Scientific is a venture-backed materials discovery engine utilizing our proprietary FEMART simulation software. Velar Scientific is actively raising a Seed round to commercialize first-principles simulation for the high-temperature superconductor and fusion energy markets.
We pursue federal research grants and collaborate with national laboratories on fundamental physics problems that require long-horizon institutional support.
We work with academic institutions whose discoveries are ready for applied development, providing the engineering and commercial infrastructure to bring them forward.
We partner with investors who understand that the most transformative technologies require patient capital and integrated expertise to reach the market.